NCT05580367

Brief Summary

Survivors of critical illness commonly experience long-lasting cognitive, mental health and physical impairments. Clinically significant symptoms of anxiety, depression, and post-traumatic stress disorder (PTSD) may occur in 40%, 34% and 20% of ICU survivors respectively, compared to 6%, 8% and 4% in the general population. These symptoms can persist for more than 8 years. Evidence shows the existence of a two-way, communication network between gut microbes and the brain referred to as the gut-brain axis. Changes in the microbiome and dysregulation of this communication network in relatively healthy people is associated with cognitive dysfunction and mood disorders such as anxiety and depression. The physiological stress associated with critical illness itself and many ICU interventions including the use of mechanical ventilation and medications such as antibiotics, antacids, vasopressors, and steroids can influence the balance of the gut microbiome and associated metabolites. This observation study aims to:

  1. 1.Quantify and measure dynamic changes in the gut microbiome and its metabolites during critical illness and recovery.
  2. 2.Explore the associations between microbiome and metabolomic changes during critical illness and psychological symptoms in the patient during their recovery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 11, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 14, 2022

Completed
4 months until next milestone

Study Start

First participant enrolled

February 14, 2023

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2024

Completed
Last Updated

April 14, 2023

Status Verified

April 1, 2023

Enrollment Period

1.7 years

First QC Date

October 11, 2022

Last Update Submit

April 12, 2023

Conditions

Outcome Measures

Primary Outcomes (4)

  • Gut microbiome changes

    Quantify and measure dynamic changes in the gut microbiome and its metabolites during critical illness and recovery. (The number and diversity of microbe present)

    3 months post-discharge

  • Microbiome, metabolic changes and psychological symptoms

    Explore the associations between microbiome and metabolomic changes during critical illness and psychological symptoms in the patient during their recovery.

    3 months post-discharge

  • Gut microbial and metabolic signatures

    Investigate the potential for gut microbial and metabolic signatures at admission and discharge to predict the future development of psychological symptoms following ICU discharge.

    3 months post-discharge

  • Sample repository

    Establish a sample repository for future analysis for future studies.

    3 months post-discharge

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with an unplanned admission to critical care who are mechanically ventilated

You may qualify if:

  • Unplanned admission to critical care
  • Aged ≥18 years old
  • Requiring mechanical ventilation
  • Commencing ventilation within the previous 24 hours
  • Expected to be ventilated for minimum of ≥72 hours

You may not qualify if:

  • Known prior diagnosis of cognitive impairment
  • Known prior mental ill health
  • Known malignancy
  • Admitted after presenting with any of the following conditions:
  • trauma
  • brain injury
  • surgery
  • cardiac arrest
  • immunosuppressed
  • underlying pyogenic infection
  • Not expected to survive to completion of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Southampton NHS Foundation Trust

Southampton, United Kingdom

RECRUITING

MeSH Terms

Conditions

Critical Illness

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 11, 2022

First Posted

October 14, 2022

Study Start

February 14, 2023

Primary Completion

November 1, 2024

Study Completion

November 1, 2024

Last Updated

April 14, 2023

Record last verified: 2023-04

Locations